2 completed, 1 withdrawn. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow gp96: new trials by email Literature Review of gp96 trials Research Report on gp96
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer gp96-Ig Vaccine, Theophylline, Oxygen - Non-Small Cell Lung Cancer, Non-small-cell Lung Carcinoma | Phase 1 | Withdrawn | Eckhard Podack | 2014-12-01 | 2014-11-17 | |
| Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 gp96 - Glioma | Phase 1 | Completed | Cure&Sure Biotech Co., LTD | 20 | 2013-07-01 | 2017-11-17 |
| GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma HSPPC-96, Standard Surgical Resection - Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 96 | 2005-11-18 | 2021-05-13 |
Brain Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Central Nervous System Neoplasms (1) · Glioblastoma (1) · Glioma (1) · Lung Neoplasms (1)
Cure&Sure Biotech Co., LTD (1) · Eckhard Podack (1) · University of California, San Francisco (1)
China (1) · United States (1)
Ikechukwu Akunyili, MD (1) · Jennifer Clarke, MD (1) · Zhixian Gao, Doctor (1)
P50CA097257 (1), R01CA164714 (1)